Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis
-
Published:2017-09
Issue:
Volume:404
Page:79-88
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Schoenhacker-Alte Beatrix,
Mohr Thomas,
Pirker Christine,
Kryeziu Kushtrim,
Kuhn Paul-SteffenORCID,
Buck Alicia,
Hofmann Thilo,
Gerner Christopher,
Hermann Gerrit,
Koellensperger Gunda,
Keppler Bernhard K.,
Berger Walter,
Heffeter Petra
Subject
Cancer Research,Oncology
Reference44 articles.
1. Platinum antitumor complexes: 50 Years since Barnett Rosenberg's discovery;Muggia;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2015
2. Toxicity of platinum compounds;Hartmann;Expert Opin. Pharmacother.,2003
3. Safety and activity ot IT-139, a ruthenium-based compound, in patients with advanced solid tumors: a first-in-human, open label, dose escalation phase 1 study with expansion cohort;Burris;ESMO Open,2016
4. Biodistribution of the novel anticancer drug sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] KP-1339/IT139 in nude BALB/c mice and implications on its mode of action;Bytzek;J. Inorg. Biochem.,2016
5. CF3 derivatives of the anticancer Ru(III) complexes KP1019, NKP-1339, and their imidazole and pyridine analogues show enhanced lipophilicity, albumin interactions, and cytotoxicity;Chang;Inorg. Chem.,2016
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献